Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
news_6

Tricor & Financial Times Board Director Programme Report Reveals Critical Gaps for Boards in Singapore in Digital Governance, Cybersecurity and Risk Management

SINGAPORE--(BUSINESS WIRE)--Tricor Group and the Financial Times Board Director Programme co-released the inaugural Asia Pacific Board Director Barometer Report, uncovering...

news_6

Tricor & Financial Times Board Director Programme Report Reveals Critical Gaps for Boards in Singapore in Digital Governance, Cybersecurity and Risk Management

SINGAPORE--(BUSINESS WIRE)--Tricor Group and the Financial Times Board Director Programme co-released the inaugural Asia Pacific Board Director Barometer Report, uncovering...

news_6

Tricor & Financial Times Board Director Programme Report Reveals Critical Gaps for Boards in Singapore in Digital Governance, Cybersecurity and Risk Management

SINGAPORE--(BUSINESS WIRE)--Tricor Group and the Financial Times Board Director Programme co-released the inaugural Asia Pacific Board Director Barometer Report, uncovering...

news_6

Tricor & Financial Times Board Director Programme Report Reveals Critical Gaps for Boards in Japan in Digital Governance, Cybersecurity and Risk Management

TOKYO--(BUSINESS WIRE)--Tricor Group and the Financial Times Board Director Programme co-released the inaugural Asia Pacific Board Director Barometer Report, uncovering...

news_6

Tricor & Financial Times Board Director Programme Report Reveals Critical Gaps for Boards in Australia in Digital Governance, Cybersecurity and Risk Management

SYDNEY--(BUSINESS WIRE)--Tricor Group and the Financial Times Board Director Programme co-released the inaugural Asia Pacific Board Director Barometer Report, uncovering...

news_6

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer